- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07235124
Motivation und Neurotransmitter bei Ruderern
Psychobiologische Korrelate der Leistungsmotivation und Neurotransmitterreaktionen auf körperliche Betätigung bei Elite-Ruderern
The goal of this observational study is to learn how motivation and body chemistry are linked during and after intense exercise in national-level rowers.
The main questions this study aims to answer are:
Do athletes with higher motivation show different changes in brain chemicals after exercise? How do hormone and neurotransmitter levels change during recovery after exercise?
Participants will:
Complete a motivation questionnaire called the Inventory of Achievement Motivation (LMI) before the exercise test.
Perform a 6000-meter rowing test on an indoor rowing machine. Have blood samples taken three times: before exercise, immediately after exercise, and 1 hour after exercise.
Researchers will measure blood levels of testosterone, cortisol, serotonin, dopamine, beta-endorphin, anandamide (AEA), and 2-arachidonoylglycerol (2-AG).
This study will help researchers understand how motivation and body chemistry work together to influence performance and recovery in highly trained athletes.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
This study explores how motivation and body chemistry are connected during and after intense physical exercise in national-level rowers. Researchers want to understand how psychological factors, such as motivation to achieve goals, relate to changes in hormones and brain chemicals that occur with exercise and recovery.
Before the exercise test, participants will complete a motivation questionnaire called the Inventory of Achievement Motivation (LMI). This questionnaire helps identify how strongly a person is driven to perform, overcome challenges, and reach success.
After the questionnaire, each participant will complete a 6000-meter rowing test on an indoor rowing machine. This test is designed to produce a high level of physical effort similar to competition conditions. Blood samples will be taken three times: before the test, immediately after the test, and one hour after recovery.
The blood samples will be used to measure levels of several hormones and neurotransmitters, including testosterone, cortisol, serotonin, dopamine, beta-endorphin, anandamide (AEA), and 2-arachidonoylglycerol (2-AG). These substances are involved in stress response, motivation, reward, and recovery.
Researchers will compare the results from the motivation questionnaire with changes in hormone and neurotransmitter levels. The goal is to find out whether more motivated athletes show different chemical responses to exercise and recovery.
Findings from this study may improve understanding of how the mind and body interact during intense training. This knowledge could help athletes and coaches develop better ways to support motivation, performance, and recovery in high-level sports.
Studientyp
Einschreibung (Tatsächlich)
Kontakte und Standorte
Studienorte
-
-
Greater Poland Voivodeship
-
Poznan, Greater Poland Voivodeship, Polen, 61-871
- Poznań University of Physical Education
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Probenahmeverfahren
Studienpopulation
All participants were recruited and tested at the Central Sports Centre - Olympic Preparation Center (COS OPO) in Wałcz, Poland, during a national team training camp under standardized conditions.
Beschreibung
Inclusion Criteria:
National-level male rowers Age between 18 and 25 years Minimum of 3 years of systematic rowing training Regular training load (at least 10 sessions per week during the competitive season) Good general health and medical clearance for maximal exercise testing
Exclusion Criteria:
Current illness, injury, or infection Use of medications or dietary supplements that could affect hormone or neurotransmitter levels Smoking or use of psychoactive substances Inadequate sleep or food intake before testing Refusal or inability to provide informed consent
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Beobachtungsmodelle: COHORT
- Zeitperspektiven: RETROSPECTIVE
Kohorten und Interventionen
Gruppe / Kohorte |
Intervention / Behandlung |
|---|---|
|
Rowers
The study includes 24 national-level male rowers. All participants are healthy, highly trained athletes with at least 3 years of systematic rowing experience and regular intensive training. |
Participants perform a 6000-meter rowing test on an indoor ergometer at maximal effort to simulate race conditions and induce physiological fatigue. |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Changes in serum Cortisol levels
Zeitfenster: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of Cortisol serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in serum Testosterone levels
Zeitfenster: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of Testosterone serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in serum Dopamin levels
Zeitfenster: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of Dopamin serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in serum Serotonin levels
Zeitfenster: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of Serotonin serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in serum Beta-endorphin levels
Zeitfenster: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of Beta-endorphin serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in serum anandamide (AEA) levels
Zeitfenster: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of anandamide (AEA) serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in serum 2-arachidonoylglycerol (2-AG)) levels
Zeitfenster: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of 2-arachidonoylglycerol (2-AG) serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Changes in Testosterone-to-cortisol ratio (T:C)
Zeitfenster: Before exercise, immediately after, and 1 hour after recovery
|
Ratio calculated from serum testosterone and cortisol concentrations (ng/mL), used as an indicator of anabolic-catabolic balance. |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in TSerotonin-to-dopamine ratio (S:D)
Zeitfenster: Before exercise, immediately after, and 1 hour after recovery
|
Ratio of serum serotonin to dopamine concentrations (ng/mL), reflecting neurochemical balance related to motivation and fatigue. |
Before exercise, immediately after, and 1 hour after recovery
|
|
Achievement Motivation (LMI score)
Zeitfenster: Before exercise (baseline)
|
Assessment of achievement motivation using the Inventory of Achievement Motivation (LMI). The questionnaire evaluates multiple dimensions of motivation, such as persistence, confidence in success, goal setting, and compensatory effort. Total and subscale scores are analyzed to identify individual motivational profiles. |
Before exercise (baseline)
|
Mitarbeiter und Ermittler
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- LMI60002023
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
Individual participant data (IPD) will not be shared. Data will be used only for internal analysis and dissemination in scientific publications in aggregate form, in accordance with ethical approval.
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .